AN2 Therapeutics

ANTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$213.576 M

$5.93 -2.47%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$35.2M

Loss-making

Shares outstanding

35,941,195

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#260Keros TherapeuticsKROS$221.1M
#261Siga TechnologiesSIGA$218.8M
#262AN2 TherapeuticsANTX$213.6M
#263Atrium TherapeuticsRNA$211.1M
#264Greenwich LifeSciencesGLSI$210.8M

Where these numbers come from

Share counts and financials for AN2 Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.